ghk-cu + bpc-157 BPC-157/NAD+/GUK-Cu - Peptide Patch GLOW 70 Peptide Blend |

Intravenous infusions and/or injections of more than a total of 100 mL per 12-hour period except for those legitimately received in the course of hospital treatments, surgical procedures or clinical diagnostic investigations

There is no pharmacokinetic reason to separate the injection days

These drugs render type 2 diabetes more manageable by lowering insulin resistance and A1C levels through the inhibition of the release of glucagon, a hormone that elevates blood sugar levels

The Glow Stack Blend is a single lyophilized vial that co-formulates three of the most-studied repair peptides in modern preclinical literature: GHK-Cu (50 mg), TB-500 (10 mg), and BPC-157 (10 mg)